(Q36307886)

13 August 2017

Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma (English)

1 reference

13 August 2017

Marta Osorio

1

1 reference

13 August 2017

Elias Gracia

2

1 reference

13 August 2017

Edmundo Reigosa

3

1 reference

13 August 2017

Julio Hernandez

4

1 reference

13 August 2017

Ana de la Torre

5

1 reference

13 August 2017

Giselle Saurez

6

1 reference

13 August 2017

Kirenia Perez

7

1 reference

13 August 2017

Carmen Viada

8

1 reference

13 August 2017

Meylán Cepeda

9

1 reference

13 August 2017

Adriana Carr

10

1 reference

13 August 2017

Yisel Avila

11

1 reference

13 August 2017

Migdalia Rodríguez

12

1 reference

13 August 2017

Luis E Fernandez

13

1 reference

13 August 2017

language of work or name

English

0 references

publication date

5 October 2012

1 reference

Cancer Management and Research

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

341-345

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

13 August 2017

start time

1 October 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

NGcGM3 ganglioside: a privileged target for cancer vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Well-defined melanoma antigens as progression markers for melanoma: insights into differential expression and host response based on stage

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Management of cutaneous melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP).

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468021

Gangliosides expressed in human breast cancer

21 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23055778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cutaneous Malignant Melanoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23055778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identification of melanoma antigens that are immunogenic in humans and expressed in vivo

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23055778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/CMAR.S22617

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

23055778

1 reference